Product
CC-91633
Aliases
BMS-986397
1 clinical trial
4 indications
Indication
LeukemiaIndication
myeloidIndication
AcuteIndication
Myelodysplastic SyndromesClinical trial
A Phase 1, Open-label, Dose-finding Study of CC-91633 (BMS-986397) in Subjects With Relapsed or Refractory Acute Myeloid Leukemia or Relapsed or Refractory Higher-Risk Myelodysplastic SyndromesStatus: Recruiting, Estimated PCD: 2026-05-05